Buscar
AtriCure Inc
ATRCAñadir a la lista de seguimiento
31.307USD
+1.577+5.31%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
1.56BCap. mercado
PérdidaP/E TTM
Más Datos de AtriCure Inc Compañía
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Información de AtriCure Inc
Símbolo de cotizaciónATRC
Nombre de la empresaAtriCure Inc
Fecha de salida a bolsaAug 05, 2005
Director ejecutivoCarrel (Michael H)
Número de empleados1300
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 05
Dirección7555 Innovation Way
CiudadMASON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal45040
Teléfono15137554100
Sitio Webhttps://www.atricure.com
Símbolo de cotizaciónATRC
Fecha de salida a bolsaAug 05, 2005
Director ejecutivoCarrel (Michael H)
Ejecutivos de AtriCure Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de AtriCure Inc?
Los cinco principales accionistas de AtriCure Inc son: Mr. Michael H. (Mike) Carrel, CPA
¿Cuántas instituciones poseen acciones de AtriCure Inc (ATRC)?
A fecha de 2026Q1, 505 instituciones poseen acciones de AtriCure Inc, con un valor de mercado combinado de aproximadamente 48.18M, lo que representa el 95.14% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -7010307.00.
¿Cuál es la mayor fuente de ganancias de AtriCure Inc?
El 2026Q1, el segmento empresarial Appendage Management-United states generó la ganancia más alta para AtriCure Inc, ascendiendo a 178.13M y representando el 33.32% de la ganancia total.